Image 1
Propranolol Hydrochloride Capsule, Extended Release
Product Images NDC 0228-2780
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Propranolol Hydrochloride (NDC 0228-2780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
Image 5
Image 6
This is a label of medication containing Propranolol Hydrochloride in an extended-release capsule form. The capsule has a 60mg dosage and is intended for usual use, as per the accompanying instructions. The medication is distributed in a pack of 100 capsules and is available by prescription only in the USA.*
Image 7
This is a description of a medication containing Propranolol Hydrochloride, which comes in an extended-release capsule and is manufactured in the USA. The dosage information is not available. The NDC number is also mentioned.*
Image 8
This is a description of a prescription drug called Propranolol Hydrochloride, which is an extended-release capsule. The capsules contain 120mg of the active ingredient and are manufactured by Actavis Pharmaceuticals. It is not clear what the indication for use of the drug is.*
Image 9
This appears to be a product label for Propranolol Hydrochloride extended-release capsules. The capsules come in a pack of 100 and contain 160 mg of the active ingredient. The dosage instructions are not available in the given text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
